Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax
Junya Sango, Saul Carcamo, Maria Sirenko, et al.
Nature (2024) Vol. 636, Iss. 8041, pp. 241-250
Open Access | Times Cited: 11

Showing 11 citing articles:

Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations
Indranil Singh, Daniel Fernández-Pérez, Pedro Sanchez Sanchez, et al.
Cell stem cell (2025)
Open Access | Times Cited: 1
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1
Evan C. Chen, Shai Shimony, Marlise R. Luskin, et al.
American Journal of Hematology (2025)
Closed Access
The chromatin accessibility landscape of pediatric AML
Ambre Giguelay, Leif S. Ludwig
Blood (2025) Vol. 145, Iss. 11, pp. 1109-1111
Closed Access
Antiaging for Ph-like ALL: targeting senescence
Ilaria Iacobucci
Blood (2025) Vol. 145, Iss. 11, pp. 1107-1109
Closed Access
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
Andrius Žučenka, Milvydė Tamutytė
Frontiers in Oncology (2025) Vol. 15
Open Access
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
Tao Wang, Junxia Huang, Yongqian Jia, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance
Sumiko Takao, Victor Morell, Masahiro Uni, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Unraveling Venetoclax Resistance: Navigating the Future of HMA/Venetoclax-Refractory AML in the Molecular Era
Theodora Chatzilygeroudi, Theodoros Karantanos, Vasiliki Pappa
Cancers (2025) Vol. 17, Iss. 9, pp. 1586-1586
Open Access
Taurine from tumour niche drives glycolysis to promote leukaemogenesis
Sonali Sharma, Benjamin Rodems, Cameron Baker, et al.
Nature (2025)
Open Access
Mapping of Functional Metabolic Phenotypes in Acute Myeloid Leukemia
Sissel E. Dyrstad, Kimberley Joanne Hatfield, Endre Stigen, et al.
Cancer Medicine (2025) Vol. 14, Iss. 10
Open Access
Models to study myelodysplastic syndrome and acute myeloid leukaemia
C. Chao, Ismael El Hajra, Elvin Wagenblast
Current Opinion in Hematology (2024)
Closed Access | Times Cited: 1
Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?
Foteini Fotopoulou, Esther Rodríguez-Correa, Charles Dussiau, et al.
Experimental Hematology (2024), pp. 104698-104698
Closed Access | Times Cited: 1
Genotype-immunophenotype relationships inNPM1-mutant AML clonal evolution uncovered by single cell multiomic analysis
Morgan Drucker, Darren Lee, Xuan Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top